You are leaving our website

You have clicked on a link that will take you to a third-party website that Alliance Pharmaceuticals plc group (“Alliance”) is not responsible for.

Please read the following disclaimer and click “I agree” to proceed to the third-party website.

By clicking to continue you agree that:You are leaving Alliance`s website.

Alliance:

  • Is not responsible for the content or accuracy of the third-party website nor endorse or guarantee any services or information they may offer.
  • Does not represent either the third-party website or you (the visitor) if you enter into an agreement or transaction.
  • Privacy and security policies do not apply to third-party websites.
or Decline

Appointment of Non-Executive Director - 26 Jan 2015

ALLIANCE PHARMA PLC

("Alliance" or the "Group")

Alliance Pharma plc is pleased to announce the appointment of Nigel Clifford as an independent Non-Executive Director of the Company. Nigel will join the Board with immediate effect.

Nigel is Chief Executive of Procserve Holdings Limited, a leading company in enabling secure transactions online. He is also currently a non-executive director of Anite plc. He has previously held senior positions at Micro Focus International plc, Nokia, Symbian Software Ltd, Tertio Telecoms Limited, Cable and Wireless plc, Glasgow Royal Infirmary NHS Trust and BT plc.

“We are delighted to welcome Nigel to the Board of Alliance. His breadth of business experience and his significant exposure to international and European markets make him a strong addition to the Alliance team.”

Andrew Smith, Chairman of Alliance

The following information is disclosed pursuant to Schedule Two paragraph (g) of the AIM Rules for Companies. Nigel Richard Clifford, aged 55 years, has been a director of the following companies during the five years preceding the date of this announcement:

Swipe to see more
Current directorshipsPast Directorships
Anite plcSymbian Limited
Procserve Holdings LimitedSymbian Software Limited
Procserve Services LimitedMicro Focus International plc
Procserve Shared Services Limited
Procserve Solutions Limited
Procserve Supplier Solutions Limited
Swipe to see more

There is no further information to be disclosed pursuant to Rule 17 or Schedule Two paragraph (g) of the AIM Rules for Companies.

For further information:

Alliance Pharma plc + 44 (0)1249 466966
Peter Butterfield, Chief Executive Officer
Andrew Franklin, Chief Financial Officer

Buchanan + 44 (0)20 7466 5000
Mark Court / Sophie Wills / Hannah Ratcliff

Numis Securities Limited + 44 (0)20 7260 1000
Nominated Adviser: Michael Meade / Freddie Barnfield
Corporate Broking: James Black

Investec Bank plc + 44 (0)20 7597 5970
Corporate Finance: Daniel Adams / Ed Thomas
Corporate Broking: Patrick Robb / Tejas Padalkar

Notes to editors:

About Alliance

Alliance, founded in 1998, is an AIM listed speciality pharmaceutical company based in Chippenham, Wiltshire, UK. The Company has a strong track record of acquiring the rights to established niche products and owns or licenses the rights to more than 60 pharmaceutical products and continues to explore opportunities to expand the range.

Alliance joined the AIM market of the London Stock Exchange in December 2003 and trades under the symbol APH.